JACOBS LEVY EQUITY MANAGEMENT, INC - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,127,000
-39.7%
62,645
-14.9%
0.01%
-40.0%
Q2 2020$1,869,000
+375.6%
73,572
+312.7%
0.02%
+400.0%
Q4 2019$393,000
-14.4%
17,829
-44.2%
0.00%
-33.3%
Q3 2019$459,000
+188.7%
31,929
-42.3%
0.01%
+100.0%
Q4 2016$159,000
-51.5%
55,319
-0.7%
0.00%
-50.0%
Q3 2016$328,000
+15.9%
55,719
-41.0%
0.01%0.0%
Q2 2016$283,000
-17.5%
94,419
+47.7%
0.01%
-14.3%
Q1 2016$343,00063,9460.01%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 4,080,237$103,638,00010.86%
Aquilo Capital Management, LLC 1,454,686$36,949,0007.45%
RTW INVESTMENTS, LP 7,152,918$181,684,0005.11%
EcoR1 Capital, LLC 2,721,993$69,139,0005.11%
BRIDGER MANAGEMENT, LLC 1,473,568$37,429,0003.47%
DAFNA Capital Management LLC 454,236$11,538,0003.33%
Parkman Healthcare Partners LLC 300,805$7,640,0002.15%
ACUTA CAPITAL PARTNERS, LLC 170,000$4,318,0001.25%
Integral Health Asset Management, LLC 110,000$2,794,0000.84%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,013,087$25,732,0000.63%
View complete list of DICERNA PHARMACEUTICALS INC shareholders